Abstract
Paraneoplastic cerebellar degeneration (PCD) is a rare syndrome associated with systemic malignancies, most in lung and ovarian cancer. Cerebellar ataxia has previously been associated with the presence of anti-Purkinje cell antibodies (anti-Yo) in the serum and cerebrospinal fluid and responses to therapy are uncommon. We reported two patients were identified with delayed onset of PCD associated with high titer of CSF anti-Yo (1:30,000, 1:320 U/ml) and a marked elevation of tumor markers for ovarian cancer (CA-125 17,700 ng/ml, 43 ng/ml) titer 1 year and 6 months prior to discovery of the carcinoma. Both developed subacute onset of severe ataxia, dysarthria, tremor, nystagmus with progression to severe debilitation (wheelchair bound or bedridden status). One of these patients also developed dysphagia that required PEG tube feeding. They were treated with six cycles of intravenous immunoglobulin (IVIG) 0.4 gm/kg/day × 5 days, every 4–6 weeks in conjunction with combination chemotherapy of Taxol and Carboplatin after the surgical resection of ovarian cancer. In each case, a significant improvement of neurological deficits were seen after the third cycle of IVIG, approximately 4 months after initiation of treatment. This type of delayed response is contrary to the previous reports. Both patients could ambulate without assistance in correlation with dramatic decrease in anti-Yo titer (1:80, 1:320 U/ml) and CA-125 (11 ng/ml, 8 ng/ml). This is a first report of benefit from IVIG in patients with late onset of PCD, which showed a delayed response with significant neurological improvement.
Similar content being viewed by others
References
Ratko TA, Burnett DA, Foulke GE, et al (1995) Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 273:l865–l870
Schwartz SA (1990) Intravenous immunoglobulin for the therapy of autoimmune disorders. J Clinical Immunol 10(2):80–89
McCrystal M., Anderson NE, Jones RW, Evans BD (1995) Paraneoplastic cerebellar degeneration in a patient with chemotherapy responsive ovarian cancer. Int J Gynecol Cancer 5:396–399
Moll JWB, Himden-Loggman SC, Vandur-Mesche FGA, Vescht CHJ (1993) Letter to the Editor: Early diagnosis in intravenous immunoglobulin therapy and paraneoplastic cerebellar degeneration. J Neurol Neurosurg, Psychiatry 56:112
Brower B (1919) Beitrag zur kenntnis der chronischen diffusen kleinhimerkrankunger. Medels Neurol Zentralbatt; 38:674–682
Brain R, Wilkinson M (1965) Subacute cerebellar degeneration associated with neoplasms. Brain 8:465–478
Anderson NE, Rosenblum MK, Posner JB (1988) Paraneoplastic cerebellar degeneration: clinic and neurologic correlations. Ann Neurol 24:559–567
Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti- Yo antibody-positive patients. Neurology 42:1931–191
Hetzel DJ, Stanhope CR, O’Nell VP, Lennon VA (1990) Gynecologic cancer with subacute cerebellar degeneration predicted by Anti-Purkinje cell antibodies in a limited and metastatic volume. Mayo Clin Proc 65(12):1558–1563
Paone IF, Jeyasingham KJ (1980) Remission of cerebellar dysfunction of pneumonectomy for bronchiogenic carcinoma. N Engl J Med 3:156
Rewcastle NB (1963) Subacute cerebellar degeneration with Hodgkin’s disease. Arch Neurology 9:407–413
Fumeaux HM, Rosenblum MK, Dolmer J (1990) Selective expression of Purkinje-cell antigens in tumor tissue from paraneoplastic degeneration. N Engl J Med 322: 1844–1851
Cocconi G, Ceri G, Juvorra G, Alt ET (1985) Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 56:2318–2320
Acknowledgment
Surasak Phuphanich, MD was supported in part by a Georgia Cancer Coalition Distinguished Clinical Investigator Professorial Award. We gratefully acknowledge the excellent editing assistance of Ms. Melissa Phuphanich.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Phuphanich, S., Brock, C. Neurologic Improvement after High-dose Intravenous Immunoglobulin Therapy in Patients with Paraneoplastic Cerebellar Degeneration Associated with Anti-Purkinje Cell Antibody. J Neurooncol 81, 67–69 (2007). https://doi.org/10.1007/s11060-006-9198-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-006-9198-x